Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia

Wong, Li Ping; Alias, Haridah; Siaw, Yan-Li; Muslimin, Mustakiza; Lai, Lee Lee; Lin, Yulan; Hu, Zhijian

doi:10.1080/21645515.2022.2078634

Cited by 34 publications

(45 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Among social and demographic determinants, our findings indicate that booster hesitancy is higher at younger ages [27][28][29] , unlike some previous studies that reported greater booster hesitancy among older persons 30 . Our findings of greater hesitancy among those with lower educational attainment 31 and lower income 17 are consistent with the literature and unchanged from our previous reports 5,6 .…”

Section: Discussioncontrasting

confidence: 96%

“…Our findings of greater hesitancy among those with lower educational attainment 31 and lower income 17 are consistent with the literature and unchanged from our previous reports 5,6 . Similarly, our booster coverage ranges align with the existing literature-for example, from 7% in China 32 to more than 40% in Jordan 33 , Malaysia 30 and the United States 31 . These rates were included in country-specific reports using different data sources, methodologies and chronology, whereas ours are reported on 23 countries simultaneously using a standardized method of data collection and analysis.…”

Section: Discussionsupporting

confidence: 82%

See 1 more Smart Citation

A survey of COVID-19 vaccine acceptance across 23 countries in 2022

Lazarus

Wyka

White

et al. 2023

Nat Med

231

111

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 96%

Section: Discussionsupporting

confidence: 82%

A survey of COVID-19 vaccine acceptance across 23 countries in 2022

Lazarus

Wyka

White

et al. 2023

Nat Med

231

111

View full text Add to dashboard Cite

show abstract

“…Numerous studies in countries outside China showed a lower willingness to the booster dose of COVID‐19 vaccine than our study, 27–34 exclusive of one carried out in Japan declaring 97.9% of participants intended to accept a third dose 35 . This finding was consistent with the conclusions drawn in reviews that vaccine acceptance was higher in low‐income countries than in the high‐income ones generally 36,37 .…”

Section: Discussionsupporting

confidence: 91%

Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS‐CoV‐2: A cross‐sectional study in Puyang city, China

Zhou

Zhao

et al. 2022

Journal of Medical Virology

View full text Add to dashboard Cite

We aimed to investigate the hesitancy and willingness of parents to vaccinate themselves and their children with a booster dose against severe acute respiratory syndrome coronavirus 2 and related factors. We conducted a cross‐sectional study in Puyang city, China. The information was collected, including demographic characteristics, willingness to receive a booster dose of coronavirus disease 2019 (COVID‐19) vaccine, and attitudes and concerns toward COVID‐19 and vaccines. Vaccine hesitancy was assessed in individuals completing the first two doses and booster eligible, while vaccine willingness was assessed in those completing the first two doses and not yet booster eligible. Among the participants completing two primary doses while not meeting the booster criteria, 95.4% (1465/1536) and 95.0% (1385/1458) had a willingness to a booster dose of COVID‐19 vaccine for themselves and their children, respectively. Among the participants who met the booster criteria, 40.3% had vaccine hesitancy. Vaccine hesitancy and unwillingness tended to occur in people who were younger, less educated, less healthy, and with unsureness of vaccines' efficacy and adverse events (AE). The younger age of children, children in poorer health, and concern about the efficacy and AE of vaccines contributed to the participants' unwillingness to vaccinate their children. We observed a high willingness to the booster dose of COVID‐19 vaccine both for the parents and their children, regardless of the eligibility to a booster dose. However, 40% of people had delayed vaccination behaviors. The promotion of scientific knowledge of vaccines' effectiveness and safety is needed, especially for people in poor health and parents with young children. Timely disclosure of AE caused by COVID‐19 vaccines and proper aiding offered to people encountering AE are suggested.

show abstract

“…Educational level was a strong predictor as well, according to several included studies [ 28 , 37 , 45 , 52 , 61 , 65 , 68 , 69 , 70 , 72 , 76 ]. Being a HCW was another predictor in 2 studies [ 48 , 74 ], while a previous COVID-19 infection in the family was a predictor in 5 studies [ 28 , 49 , 60 , 61 , 63 ]. Employment status and personal/household income were predictors among several studies [ 47 , 51 , 56 , 61 , 72 , 76 , 81 ].…”

Section: Resultsmentioning

confidence: 99%

COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis

et al. 2022

View full text Add to dashboard Cite

The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-19) booster dose vaccination after completing the primary vaccination series for individuals ≥18 years and most-at-risk populations. This study aimed to estimate the pooled proportion of COVID-19 vaccine booster dose uptake and intention to get the booster dose among general populations and healthcare workers (HCWs). We searched PsycINFO, Scopus, EBSCO, MEDLINE Central/PubMed, ProQuest, SciELO, SAGE, Web of Science, Google Scholar, and ScienceDirect according to PRISMA guidelines. From a total of 1079 screened records, 50 studies were extracted. Meta-analysis was conducted using 48 high-quality studies according to the Newcastle-Ottawa Scale quality assessment tool. Using the 48 included studies, the pooled proportion of COVID-19 vaccine booster dose acceptance among 198,831 subjects was 81% (95% confidence interval (CI): 75–85%, I2 = 100%). The actual uptake of the booster dose in eight studies involving 12,995 subjects was 31% (95% CI: 19–46%, I2 = 100%), while the intention to have the booster dose of the vaccine was 79% (95% CI: 72–85%, I2 = 100%). The acceptance of the booster dose of COVID-19 vaccines among HCWs was 66% (95% CI: 58–74%), I2 = 99%). Meta-regression revealed that previous COVID-19 infection was associated with a lower intention to have the booster dose. Conversely, previous COVID-19 infection was associated with a significantly higher level of booster dose actual uptake. Subgroup analyses revealed that the pooled booster dose acceptance in the WHO region of the Americas, which did not include any actual vaccination, was 77% (95% CI: 66–85%, I2 = 100%). The pooled acceptance of the booster dose in the Western Pacific was 89% (95% CI: 84–92%, I2 = 100), followed by the European region: 86% (95% CI: 81–90%, I2 = 99%), the Eastern Mediterranean region: 59% (95% CI: 46–71%, I2 = 99%), and the Southeast Asian region: 52% (95% CI: 43–61%, I2 = 95). Having chronic disease and trust in the vaccine effectiveness were the significant predictors of booster dose COVID-19 vaccine acceptance. The global acceptance rate of COVID-19 booster vaccine is high, but the rates vary by region. To achieve herd immunity for the disease, a high level of vaccination acceptance is required. Intensive vaccination campaigns and programs are still needed around the world to raise public awareness regarding the importance of accepting COVID-19 vaccines needed for proper control of the pandemic.

show abstract

Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia

Cited by 34 publications

References 34 publications

A survey of COVID-19 vaccine acceptance across 23 countries in 2022

A survey of COVID-19 vaccine acceptance across 23 countries in 2022

Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS‐CoV‐2: A cross‐sectional study in Puyang city, China

COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About